Cancer Monoclonal Antibodies Market Size By Application, Industry Analysis Report, Regional Outlook (North America, Europe, Asia Pacific, Middle East & Africa, And South America), Growth Potential, Price Trends, Competitive Market Share & Forecast 2023 - 2030 (Financial Impact Analysis)
ID : MRU_
3354 | Date :
Jan, 2023 | Pages :
180 | Region : Global |
Publisher : 99 Strategy
The mAbs, which are produced by genetic engineering, target antigens in cells, tissues, and organs. They are used in clinical applications to treat diseases with excellent efficacy and minimal side effects. Their MOA, absence of generic pathway, and therapeutic applications distinguish them from other targeted therapeutics.
Cancer is one of the leading causes of death globally. There were 10.9 million new cases, in 2002, which increased to 14.1 million, in 2012 (approximately 30% growth in a decade). The WHO expects this number to increase by 70%, over the next two decades. According to the WHO, almost 70% of deaths occur in low and middle-income countries. The increment in data is expected to provide the basis for any national policy on cancer, leading to an increase in the percentage of people choosing cancer treatment. In the healthcare sector, cancer is one of the biggest concerns. Thus, the increased use of monoclonal antibodies for the treatment of cancer is driving this market.
Monoclonal Antibodies having the potential to offer less toxic and efficient therapeutic alternatives to the patients have been emerging in the recent years. Monoclonal Antibodies are used to treat a wide array of diseases related to autoimmune, inflammatory and especially cancer. Monoclonal Antibodies (mAbs) are mono-specific antibodies bodies comprising of identical immune cells that are clones of a single parent cells and are directed to a specific cellular targets. Thus Monoclonal Antibodies are highly customizable due to its specific nature and can play a crucial role in eliminating the cancerous cell while sparing the normal cells during the cancer treatment. The monoclonal antibodies are proved to be more effective than chemotherapies and drugs for cancer treatment.
The Global Cancer Monoclonal Antibodies Market was valued at xxx million USD with a CAGR xx% from 2018-2022. Subsequently, it will touch xxx million USD in 2023 with a CAGR xx % from 2023-2030.
In the global Cancer Monoclonal Antibodies Market, This report focuses particularly in North America, South America, Europe and Asia-Pacific, and Middle East and Africa. This report classifies the Market on the basis of application, type, regions, and manufactures.
In Market segmentation by manufacturers, the report covers the following companies-
F. Hoffmann-La Roche
Amgen
Bristol-Myers Squibb
Takeda Pharmaceuticals
In Market segmentation by geographical regions, the report has analysed the following regions-
North America (USA, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Columbia etc.)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
In Market segmentation by types :
Murine Antibodies
Chimeric and Humanised Antibodies
Fully Humanized Antibodies
Others
In Market segmentation by applications :
Liver
Breast
Blood
Brain
Hodgkins and Non-Hodgkins lymphoma
Colorectal
Leukaemia
Others
The research provides answers to the following key questions:
• What is the estimated growth rate and Market share and size of the Cancer Monoclonal Antibodies Market for the forecast period 2023-2030?
• What are the driving forces in the Cancer Monoclonal Antibodies Market for the forecast period 2023-2030?
• Who are the prominent Market players and how have they gained a competitive edge over other competitors?
• What are the Market trends influencing the progress of the Cancer Monoclonal Antibodies industry worldwide?
• What are the major challenges and threats restricting the progress of the industry?
• What opportunities does the Market hold for the prominent Market players? Any special requirements about this report, please let us know and we can provide custom report.
Note – In order to provide more accurate market forecast, all our reports will be updated before delivery by considering the impact of COVID-19.
Table of Contents
1 Report Overview
1.1 Study Scope
1.2 Major Manufacturers Covered in This Report
1.3 Market Segment by Type
1.3.1 Global Cancer Monoclonal Antibodies Market Size Growth Rate by Type (2020-2030)
1.3.2 Murine Antibodies
1.3.3 Chimeric and Humanised Antibodies
1.3.4 Fully Humanized Antibodies
1.3.5 Others
1.4 Market Segment by Application
1.4.1 Global Cancer Monoclonal Antibodies Market Share by Application (2020-2030)
1.4.2 Liver
1.4.3 Breast
1.4.4 Blood
1.4.5 Brain
1.4.6 Hodgkins and Non-Hodgkins lymphoma
1.4.7 Colorectal
1.4.8 Leukaemia
1.4.9 Others
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Cancer Monoclonal Antibodies Market Size
2.1.1 Global Cancer Monoclonal Antibodies Revenue 2015-2030
2.1.2 Global Cancer Monoclonal Antibodies Sales 2015-2030
2.2 Cancer Monoclonal Antibodies Growth Rate by Regions
2.2.1 Global Cancer Monoclonal Antibodies Sales by Regions 2018 - 2022
2.2.2 Global Cancer Monoclonal Antibodies Revenue by Regions 2018 - 2022
2.3 Industry Trends
2.3.1 Market Top Trends
2.3.2 Market Drivers
3 Market Share by Manufacturers
3.1 Cancer Monoclonal Antibodies Sales by Manufacturers
3.1.1 Cancer Monoclonal Antibodies Sales by Manufacturers 2018 - 2022
3.1.2 Cancer Monoclonal Antibodies Sales Market Share by Manufacturers 2018 - 2022
3.2 Revenue by Manufacturers
3.2.1 Cancer Monoclonal Antibodies Revenue by Manufacturers (2018 - 2022)
3.2.2 Cancer Monoclonal Antibodies Revenue Share by Manufacturers (2018 - 2022)
3.2.3 Global Cancer Monoclonal Antibodies Market Concentration Ratio (CR5 and HHI)
3.3 Cancer Monoclonal Antibodies Price by Manufacturers
3.4 Key Manufacturers Cancer Monoclonal Antibodies Plants/Factories Distribution and Area Served
3.5 Date of Key Manufacturers Enter into Cancer Monoclonal Antibodies Market
3.6 Key Manufacturers Cancer Monoclonal Antibodies Product Offered
3.7 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Sales and Revenue for Each Type
4.1.1 Murine Antibodies Sales and Revenue (2018 - 2022)
4.1.2 Chimeric and Humanised Antibodies Sales and Revenue (2018 - 2022)
4.1.3 Fully Humanized Antibodies Sales and Revenue (2018 - 2022)
4.1.4 Others Sales and Revenue (2018 - 2022)
4.2 Global Cancer Monoclonal Antibodies Sales Market Share by Type
4.3 Global Cancer Monoclonal Antibodies Revenue Market Share by Type
4.4 Cancer Monoclonal Antibodies Price by Type
5 Market Size by Application
5.1 Overview
5.2 Global Cancer Monoclonal Antibodies Sales by Application
6 United States
6.1 United States Cancer Monoclonal Antibodies Breakdown Data by Company
6.2 United States Cancer Monoclonal Antibodies Breakdown Data by Type
6.3 United States Cancer Monoclonal Antibodies Breakdown Data by Application
7 European Union
7.1 European Union Cancer Monoclonal Antibodies Breakdown Data by Company
7.2 European Union Cancer Monoclonal Antibodies Breakdown Data by Type
7.3 European Union Cancer Monoclonal Antibodies Breakdown Data by Application
8 China
8.1 China Cancer Monoclonal Antibodies Breakdown Data by Company
8.2 China Cancer Monoclonal Antibodies Breakdown Data by Type
8.3 China Cancer Monoclonal Antibodies Breakdown Data by Application
9 Rest of World
9.1 Rest of World Cancer Monoclonal Antibodies Breakdown Data by Company
9.2 Rest of World Cancer Monoclonal Antibodies Breakdown Data by Type
9.3 Rest of World Cancer Monoclonal Antibodies Breakdown Data by Application
9.4 Rest of World Cancer Monoclonal Antibodies Breakdown Data by Countries
9.4.1 Rest of World Cancer Monoclonal Antibodies Sales by Countries
9.4.2 Rest of World Cancer Monoclonal Antibodies Revenue by Countries
9.4.3 Japan
9.4.4 Korea
9.4.5 India
9.4.6 Southeast Asia
10 Company Profiles
10.1 F. Hoffmann-La Roche
10.1.1 F. Hoffmann-La Roche Company Details
10.1.2 Company Description and Business Overview
10.1.3 Sales, Revenue and Market Share of Cancer Monoclonal Antibodies
10.1.4 Cancer Monoclonal Antibodies Product Introduction
10.1.5 F. Hoffmann-La Roche Recent Development
10.2 Amgen
10.2.1 Amgen Company Details
10.2.2 Company Description and Business Overview
10.2.3 Sales, Revenue and Market Share of Cancer Monoclonal Antibodies
10.2.4 Cancer Monoclonal Antibodies Product Introduction
10.2.5 Amgen Recent Development
10.3 Bristol-Myers Squibb
10.3.1 Bristol-Myers Squibb Company Details
10.3.2 Company Description and Business Overview
10.3.3 Sales, Revenue and Market Share of Cancer Monoclonal Antibodies
10.3.4 Cancer Monoclonal Antibodies Product Introduction
10.3.5 Bristol-Myers Squibb Recent Development
10.4 Takeda Pharmaceuticals
10.4.1 Takeda Pharmaceuticals Company Details
10.4.2 Company Description and Business Overview
10.4.3 Sales, Revenue and Market Share of Cancer Monoclonal Antibodies
10.4.4 Cancer Monoclonal Antibodies Product Introduction
10.4.5 Takeda Pharmaceuticals Recent Development
11 Value Chain and Sales Channels Analysis
11.1 Value Chain Analysis
11.2 Sales Channels Analysis
11.2.1 Cancer Monoclonal Antibodies Sales Channels
11.2.2 Cancer Monoclonal Antibodies Distributors
11.3 Cancer Monoclonal Antibodies Customers
12 Market Forecast
12.1 Global Cancer Monoclonal Antibodies Sales and Revenue Forecast 2020-2030
12.2 Global Cancer Monoclonal Antibodies Sales Forecast by Type
12.3 Global Cancer Monoclonal Antibodies Sales Forecast by Application
12.4 Cancer Monoclonal Antibodies Forecast by Regions
12.4.1 Global Cancer Monoclonal Antibodies Sales Forecast by Regions 2020-2030
12.4.2 Global Cancer Monoclonal Antibodies Revenue Forecast by Regions 2020-2030
12.5 United States Market Forecast
12.6 European Union Market Forecast
12.7 China Market Forecast
12.8 Rest of World
12.8.1 Japan
12.8.2 Korea
12.8.3 India
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.1.1 Research Programs/Design
14.1.1.2 Market Size Estimation
14.1.1.3 Market Breakdown and Data Triangulation
14.1.2 Data Source
14.1.2.1 Secondary Sources
14.1.2.2 Primary Sources
14.2 Author Details
14.3 Disclaimer
Research Methodology
The Market Research Update offers technology-driven solutions and its full integration in the research process to be skilled at every step. We use diverse assets to produce the best results for our clients. The success of a research project is completely reliant on the research process adopted by the company. Market Research Update assists its clients to recognize opportunities by examining the global market and offering economic insights. We are proud of our extensive coverage that encompasses the understanding of numerous major industry domains.
Market Research Update provide consistency in our research report, also we provide on the part of the analysis of forecast across a gamut of coverage geographies and coverage. The research teams carry out primary and secondary research to implement and design the data collection procedure. The research team then analyzes data about the latest trends and major issues in reference to each industry and country. This helps to determine the anticipated market-related procedures in the future. The company offers technology-driven solutions and its full incorporation in the research method to be skilled at each step.
The Company's Research Process Has the Following Advantages:
Information Procurement
The step comprises the procurement of market-related information or data via different methodologies & sources.
Information Investigation
This step comprises the mapping and investigation of all the information procured from the earlier step. It also includes the analysis of data differences observed across numerous data sources.
Highly Authentic Source
We offer highly authentic information from numerous sources. To fulfills the client’s requirement.
Market Formulation
This step entails the placement of data points at suitable market spaces in an effort to assume possible conclusions. Analyst viewpoint and subject matter specialist based examining the form of market sizing also plays an essential role in this step.
Validation & Publishing of Information
Validation is a significant step in the procedure. Validation via an intricately designed procedure assists us to conclude data-points to be used for final calculations.
We are flexible and responsive startup research firm. We adapt as your research requires change, with cost-effectiveness and highly researched report that larger companies can't match.
Information Safety
Market Research Update ensure that we deliver best reports. We care about the confidential and personal information quality, safety, of reports. We use Authorize secure payment process.
We Are Committed to Quality and Deadlines
We offer quality of reports within deadlines. We've worked hard to find the best ways to offer our customers results-oriented and process driven consulting services.
Our Remarkable Track Record
We concentrate on developing lasting and strong client relationship. At present, we hold numerous preferred relationships with industry leading firms that have relied on us constantly for their research requirements.
Best Service Assured
Buy reports from our executives that best suits your need and helps you stay ahead of the competition.
Customized Research Reports
Our research services are custom-made especially to you and your firm in order to discover practical growth recommendations and strategies. We don't stick to a one size fits all strategy. We appreciate that your business has particular research necessities.
Service Assurance
At Market Research Update, we are dedicated to offer the best probable recommendations and service to all our clients. You will be able to speak to experienced analyst who will be aware of your research requirements precisely.
